Великолепный мозг в любом возрасте
Великолепный мозг в любом возрасте читать книгу онлайн
Многие думают о том, как устроить личную жизнь, сделать карьеру, сохранить здоровье, молодость, красоту и т. д. Но при этом мало кто помнит о том, с чего все начинается, — о мозге. В книге доктора Д. Дж. Амена рассказывается о том, насколько наша жизнь зависит от состояния мозга и как важно улучшать и сохранять его здоровье с юности до глубокой старости. Книга основана на результатах научных исследований, проводимых автором и его коллегами с помощью новейших технологий. Каждая глава посвящена определенному аспекту нашей жизни и содержит четкие практические рекомендации. Текст книги проиллюстрирован уникальными изображениями мозга, полученными в результате компьютерного сканирования.
Внимание! Книга может содержать контент только для совершеннолетних. Для несовершеннолетних чтение данного контента СТРОГО ЗАПРЕЩЕНО! Если в книге присутствует наличие пропаганды ЛГБТ и другого, запрещенного контента - просьба написать на почту [email protected] для удаления материала
Nathan, P, S. Tanner, J. Lloyd, et al. 2004. Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans. Human Psychopharmacology 19(2): 91–96.
Singh, В., Н. Song, X. Liu, et al. 2004. Dangshen (Codonopsis pilosula) and Bai guo (Ginkgo biloba) enhance learning and memory. Alternative Therapies in Health & Medicine 10(4): 52–56.
Гюперзин A
Aisen, P. 2007. A multi- center, double- blind, placebo- controlled therapeutic trial to determine whether natural huperzine A improves cognitive function. Clinical Trials.
Ved, H., M. Koenig, J. Dave, et al. 1997. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. NeuroReport 8(4): 963–967.
Xu, S., Z. Cai, Z. Qu, et al. 1999. Huperzine- A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 20(6): 486–490.
Zhang, R., X. Tang Y. Han, et al. 1991. Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao 12(3): 250–252.
Мелатонин
Almeida Montes, L. G., M. P. Ontiveros Uribe, S. J. Cortes, et al. 2003. Treatment of primary insomnia with melatonin: A double- blind, placebo- controlled, crossover study. Journal of Psychiatry & Neuroscience 28(3): 191–196.
Cardinali, D. P, E. Gvozdenovich, and M. R. Kaplan. 2002. A doubleblind placebo-controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly. Neuroendocrinology Letters 23(1): 55–60.
Dowling, G. A., R. L. Burr, E. J. Van Someren, et al. 2008. Melatonin and brightlight treatment for rest- activity disruption in institutionalized patients with Alzheimer’s disease. Journal of the American Geriatrics Society 56(2): 239–246.
Pillar, G., Е. Shahar, N. Peled, et al. 2000. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatric Neurology 23(3): 225–228.
Smits, M. G., E. E. Nagtegaal, H. J. van der, et al. 2001. Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial. Journal of Child Neurology 16(2): 86–92.
Фосфатидилсерин
Crook, T., W. Petrie, C. Wells, et al. 1992. Effects of phosphatidyl-serine in Alzheimer’s disease. Psychopharmacology Bulletin 28: 61–66.
Hellhammer, J., E. Fries, C. Buss, et al. 2004. Effects of soy lecithin phos-phatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress. Stress 7: 119–126.
Jorissen, B. L., F. Brouns, M. P. Van Boxtel, et al. 2001. The influence of soy- derived phosphatidylserine on cognition in age- associated memory impairment. Nutritional Neuroscience 4: 121–134.
Palmieri, G., R. Palmieri, M. R. Inzoli, et al. 1987. Double- blind controlled trial of phosphatidylserine in patients with senile mental deterioration. Clinical Trials 24: 73–83.
Винпоцетин
Balestreri, R., L. Fontana, and F. Astengo. 1987. A double- blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. Journal of the American Geriatrics Society 35(5): 425–430.
Bereczki, D., and I. Fekete. 1999. A systematic review of vinpocetine therapy in acute ischaemic stroke. European Journal of Clinical Pharmacology 55(5): 349–352.
Gulyas, В., С. Halldin, Р. Karlsson, et al. 1999. Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies, [in Hungarian] . Orvusi Hetilap 140(30): 1687–1691.
Vas, A., B. Gulyas, Z. Szabo, et al. 2002. Clinical and non- clinical investigations using positron emission tomography, near infrared spectroscopy and trans — cranial Doppler methods on the neuroprotective drug vinpocetine: A summary of evidences. Journal of Neurological Science 203–204: 259–262.
Aron, A., H. Fisher, D. J., et al. 2005. Reward, motivation, and emotion systems associated with early- stage intense romantic love. Journal of Neurophysiology 94(1): 327–337.
Fisher, H., A. Aron, and L. L. Brown. 2005. Romantic love: An fMRI study of a neural mechanism for mate choice. Journal of Comparative Neurology 493(1): 58–62.
Fisher, H. E., A. Aron, D. Mashek, et al. 2002. Defining the brain systems of lust, romantic attraction, and attachment. Archives of Sexual Behavior 31(5): 413–419.
Volkow, N. D., G. J. Wang, J. S. Fowler, et al. 1999. Association of meth-ylphenidateinduced craving with changes in right striato- orbito-frontal metabolism in cocaine abusers: Implications in addiction. American Journal of Psychiatry 156(1): 19–26.
Baxter, L. R., Jr., J. M. Schwartz, K. S. Bergman, et al. 1992. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessivecompulsive disorder. Archives of General Psychiatry 49(9): 681–689.
Brody, A. L., S. Saxena, J. M. Schwartz, et al. 1998. FDG- PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Research 84(1): 1–6.
George, М. S., Т. A. Ketter, Р. I. Parekh, et al. 1995. Brain activity during transient sadness and happiness in healthy women. American Journal of Psychiatry 152(3): 341–351.
Katie, B., and S. Mitchell. 2002. Loving What Is. New York: Harmony.
Lee Duckworth, A., T A. Steen, and M. E. Seligman. 2005. Positive psychology in clinical practice. Annual Review of Clinical Psychology 1: 629–651.
Nelson, N. 2003. Power of Appreciation: The Key to a Vibrant Life. New York: Pocket.
Szloboda, P. 2008. Gratitude practices: A key to resiliency, well- being & happiness. Beginnings 28(1): 6–7.
Abramson, L. Y., M. E. P. Seligman, and J. D. Teasdale. 1978. Learned helplessness in humans — critique and reformulation. Journal of Abnormal Psychology 87: 49–74.
Amat, J., E. Paul, C. Zarza, et al. 2006. Previous experience with behavioral control over stress blocks the behavioral and dorsal raphe nucleus activating effects of later uncontrollable stress: Role of the ventral medial prefrontal cortex. Journal of Neuroscience 26: 13264-13272.
Bolognini, M., B. Plancherel, J. Laget, et al. 2003. Adolescents suicide attempts: Populations at risk, vulnerability, and substance use. Substance Use & Misuse 38(11–13): 1651–1669.
Koepp, M. J., R. N. Gunn, A. D. Lawrence, et al. 1998. Evidence for striatal dopamine release during a video game. Nature 393(6682): 266–268.
Sauzier, М. 1998. Disclosure of child sexual abuse. For better or for worse. Psychiatric Clinics of North America 12(2): 455–469.
